Reportlinker Adds Strategic Analysis of CEE IVD Market
NEW YORK, June 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Strategic Analysis of CEE IVD Market
This research service provides an analysis of various aspects of the in vitro diagnostics market in central and eastern European countries for the period between 2007 and 2017. The market has been divided into seven segments: clinical chemistry, immunodiagnostics, hematology, microbiology, point-of-care diagnostics, self-monitoring of blood glucose and molecular diagnostics. The market has been covered segment wise. Furthermore, a geographic analysis of the in vitro diagnostics market has been presented. The research service highlights main drivers and restraints for the market growth as well as challenges market participants are likely to face from 2011 to 2017.
Table of Contents
Introduction 14
Aim and Objectives 15
Research Scope and Definitions 16
Research Methodology 18
Executive Summary 19
Market Overview 20
Market Segmentation 21
Industry Challenges, Market Drivers and Restraints 22
Summary of Major Findings 23
Conclusions 27
Overview of Healthcare Industries in CEE Countries 28
Health Status 29
Healthcare System Organization 30
Healthcare Expenditure 32
Analysis of the Total CEE IVD Market 34
Introduction 35
Legal Framework 37
End User Overview 40
Key Market Trends among End Users 41
Key Technology Trends 44
Impact Assessment of Top Trends 47
Industry Challenges 48
Market Drivers 49
Market Restraints 53
Revenues Forecasts 56
Demand Analysis 58
Competitive Analysis 59
Segment Analysis 63
Market Revenues by Segment 64
Segment Lifecycle Analysis 65
Analysis of the Clinical Chemistry Market 66
Introduction 67
Market Overview 68
Key Market Trends 69
Revenues Forecasts 70
Competitive Structure 71
Analysis of the Immunodiagnostics Market 72
Introduction 73
Market Overview 74
Key Market Trends 75
Revenues Forecasts 76
Competitive Structure 77
Analysis of the Hematology Market 78
Introduction 79
Market Overview 80
Key Market Trends 81
Revenues Forecasts 82
Competitive Structure 83
Analysis of the Microbiology Market 84
Introduction 85
Market Overview 86
Key Market Trends 87
Revenues Forecasts 88
Competitive Structure 89
Analysis of the Point-of-Care Testing Market 90
Introduction 91
Market Overview 92
Key Market Trends 93
Revenues Forecasts 94
Competitive Structure 95
Analysis of the Self-monitoring of Blood Glucose Market 96
Introduction 97
Market Overview 98
Key Market Trends 99
Revenues Forecasts 100
Competitive Structure 101
Analysis of the Molecular Diagnostics Market 102
Introduction 103
Market Overview 104
Key Market Trends 105
Revenues Forecasts 106
Competitive Structure 107
Geographic Overview of the CEE IVD Market 108
IVD Market in the Czech Republic 111
Market Overview 112
Legal Framework 113
End User Overview 114
Revenues Forecasts 115
IVD Market in Hungary 116
Market Overview 117
Legal Framework 118
End User Overview 119
Revenue Forecasts 120
IVD Market in Poland 121
Market Overview 122
Legal Framework 123
End User Overview 124
Revenue Forecasts 126
IVD Market in Russia 127
Market Overview 128
Legal Framework 129
End User Overview 131
Revenues Forecasts 132
Key Findings and Recommendations 133
Key Findings 134
Recommendations 138
Appendix 140
Abbreviations 141
Research Methodology in Depth 143
Currency Exchange Rates 145
About Frost & Sullivan 146
List of Figures
Total IVD Market: Current and Future Trends by Segment (CEE), 2010 and 2017 24
Healthcare Industry: GDP Per Capita and Total Healthcare Expenditure (Europe), 2008 32
Total IVD Market: Estimated Number of Laboratories (CEE), 2010 40
Total IVD Market: Market Drivers Ranked in Order of Impact (CEE), 2011-2017 49
Total IVD Market: Market Restraints Ranked in Order of Impact (CEE), 2011-2017 53
Total IVD Market: Fluctuation of Local Currencies (CEE), 2007-2010 57
Total IVD Market: Key Market Participants in Particular Segments From Respondents' Feedback (CEE), 201059
Total IVD Market: Competitive Structure (CEE), 2010 60
Total IVD Market: Competitive Analysis of Top Market Participants (CEE), 2009-2010 61
Total IVD Market: Selected Mergers and Acquisitions (CEE), 2009-2010 62
Clinical Chemistry Market: Types of Biochemical Analyzers (CEE), 2010 67
Clinical Chemistry Market: Revenue Forecasts (CEE), 2007-2017 70
Clinical Chemistry Market: Competitive Structure (CEE), 2010 71
Immunodiagnostics Market: Revenue Forecasts (CEE), 2007-2017 76
Immunodiagnostics Market: Competitive Structure (CEE), 2010 77
Hematology Market: Types of Analyzers (CEE), 2010 79
Hematology Market: Revenue Forecasts (CEE), 2007-2017 82
Hematology Market: Competitive Structure (CEE), 2010 83
Microbiology Market: Revenue Forecasts (CEE), 2007-2017 88
Microbiology Market: Competitive Structure (CEE), 2010 89
POCT Market: Turnaround Time Differences between Laboratory and POCT Testing (CEE), 2010 91
POCT Market: Revenue Forecasts (CEE), 2007-2017 94
POCT Market: Competitive Structure (CEE), 2010 95
SMBG Market: Types of Diabetes and Frequency of Testing (CEE), 2010 97
SMBG Market: Revenue Forecasts (CEE), 2007-2017 100
SMBG Market: Competitive Structure (CEE), 2010 101
Molecular Diagnostics Market: Key Applications of Molecular Diagnostics (CEE), 2010 103
Molecular Diagnostics Market: Revenue Forecasts (CEE), 2007-2017 106
Molecular Diagnostics Market: Competitive Structure (CEE), 2010 107
IVD Market: Revenue Forecasts (The Czech Republic), 2007-2017 115
IVD Market: Revenue Forecasts (Hungary), 2007-2017 120
IVD Market: Key Potential Challenges for End Users and Possible Strategies (Poland), 2010 125
IVD Market: Revenue Forecasts (Poland), 2007-2017 126
IVD Market: Revenue Forecasts (Russia), 2007-2017 132
Total IVD Market: Comparison of Key Market Trends (Europe), 2010 136
Total IVD Market: Comparison of Key Market Trends (Europe), 2010 137
List of Charts
Total IVD Market: Industry Challenges, Market Drivers and Restraints (CEE), 2011-2017 22
Total IVD Market: Revenues Forecasts (CEE), 2007-2017 24
Total IVD Market: Per Cent of Revenues by Segment (CEE), 2017 25
Total IVD Market: Lifecycle Stage of Particular Segments (CEE), 2010 26
Healthcare Industry: Tuberculosis Prevalence (CEE), 2009 29
Healthcare Industry: Diabetes Prevalence (CEE), 2010 29
Healthcare Industry: HIV Prevalence (CEE), 2007 29
Healthcare Industry: GDP Per Capita and Total Healthcare Expenditure (Europe), 2008 32
Healthcare Industry: Public and Private Healthcare Expenditure (Europe), 2008 33
Healthcare Industry: Total Healthcare Expenditure Per Capita (Europe), 2008 33
Total IVD Market: Application of Information Obtained Through In Vitro Diagnostics (CEE), 2010 35
Total IVD Market: Role of In Vitro Diagnostics (CEE), 2010 36
Total IVD Market: EU Classification of IVD Products (CEE), 2010 38
Total IVD Market: Breakdown of Laboratory Workload (CEE), 2010 40
Total IVD Market: Motivation for Consolidation and Centralization of Laboratories (CEE), 2010 41
Total IVD Market: Typical Process of Outsourcing Laboratory Services (CEE), 2010 42
Total IVD Market: Integration and Consolidation of Laboratory Processes (CEE), 2010 45
Total IVD Market: Impact of Top Trends (CEE), 2010 47
Total IVD Market: Industry Challenges (CEE), 2011-201748
Total IVD Market: Revenues Forecasts (CEE), 2007-2017 56
Total IVD Market: Fluctuation of Local Currencies (CEE), 2007-2010 57
Total IVD Market: Value Breakdown of Demand for IVD Products (CEE), 2010 58
Total IVD Market: Per Cent of Revenues by Segment (CEE), 2010 64
Total IVD Market: Per Cent of Revenues by Segment (CEE), 2017 64
Total IVD Market: Segment Lifecycle Analysis (CEE), 2010 65
Clinical Chemistry Market: Revenue Forecasts (CEE), 2007-2017 70
Immunodiagnostics Market: Development of Immunodiagnostic Methods (CEE), 1950-2010 73
Immunodiagnostics Market: Revenue Forecasts (CEE), 2007-2017 76
Hematology Market: Revenue Forecasts (CEE), 2007-2017 82
Microbiology Market: Importance of Microbiological Testing (CEE), 2010 85
Microbiology Market: Revenue Forecasts (CEE), 2007-2017 88
POCT Market: Revenue Forecasts (CEE), 2007-2017 94
SMBG Market: Revenue Forecasts (CEE), 2007-2017 100
Molecular Diagnostics Market: Revenue Forecasts (CEE), 2007-2017 106
IVD Market: Expenditure on IVD and Healthcare Expenditure (Europe), 2009 109
Total IVD Market: Per Cent of Revenues by Country (CEE), 2010 110
Total IVD Market: Per Cent of Revenues by Country (CEE), 2017 110
IVD Market: Classification of Laboratories (The Czech Republic), 2010 114
IVD Market: Revenue Forecasts (The Czech Republic), 2007-2017 115
IVD Market: Classification of Laboratories (Hungary), 2010 119
IVD Market: Revenue Forecasts (Hungary), 2007-2017 120
IVD Market: Classification of Laboratories (Poland), 2010 124
IVD Market: Revenue Forecasts (Poland), 2007-2017 126
IVD Market: Classification of Laboratories (Russia), 2010 131
IVD Market: Revenue Forecasts (Russia), 2007-2017 132
To order this report:
In Vitro Diagnostic Industry: Strategic Analysis of CEE IVD Market
In Vitro Diagnostic Business News
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT: |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article